These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24484629)

  • 21. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers.
    Brandsma J; Goss VM; Yang X; Bakke PS; Caruso M; Chanez P; Dahlén SE; Fowler SJ; Horvath I; Krug N; Montuschi P; Sanak M; Sandström T; Shaw DE; Chung KF; Singer F; Fleming LJ; Sousa AR; Pandis I; Bansal AT; Sterk PJ; Djukanović R; Postle AD;
    Metabolomics; 2018 Sep; 14(10):123. PubMed ID: 30830396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the regulation of surfactant phosphatidylcholine metabolism using stable isotopes.
    Brandsma J; Postle AD
    Ann Anat; 2017 May; 211():176-183. PubMed ID: 28351529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
    Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alveolar surfactant subfractions differ in their lipid composition.
    Guthmann F; Haupt R; Schlame M; Stevens PA; Rüstow B
    Int J Biochem Cell Biol; 1995 Oct; 27(10):1021-6. PubMed ID: 7496991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
    Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
    Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary disease.
    Ratjen F; Rehn B; Costabel U; Bruch J
    Eur Respir J; 1996 Feb; 9(2):328-33. PubMed ID: 8777972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass spectrometric analysis of surfactant metabolism in human volunteers using deuteriated choline.
    Bernhard W; Pynn CJ; Jaworski A; Rau GA; Hohlfeld JM; Freihorst J; Poets CF; Stoll D; Postle AD
    Am J Respir Crit Care Med; 2004 Jul; 170(1):54-8. PubMed ID: 15044202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the phospholipid composition of bronchoalveolar lavage (BAL) fluid from man and minipig by MALDI-TOF mass spectrometry in combination with TLC.
    Sommerer D; Süss R; Hammerschmidt S; Wirtz H; Arnold K; Schiller J
    J Pharm Biomed Anal; 2004 Apr; 35(1):199-206. PubMed ID: 15030895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of age and breed on the phospholipid composition of canine surfactant.
    Clercx C; Venker-van Haagen AJ; den Breejen JN; Haagsman HP; van den Brom WE; de Vries HW; van Golde LM
    Lung; 1989; 167(6):351-7. PubMed ID: 2509824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible alteration of surfactant in broncho-alveolar lavage fluid from healthy smokers compared to non-smokers and patients with sarcoidosis.
    Zetterberg G; Curstedt T; Eklund A
    Sarcoidosis; 1995 Mar; 12(1):46-50. PubMed ID: 7617976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development.
    Bernhard W; Hoffmann S; Dombrowsky H; Rau GA; Kamlage A; Kappler M; Haitsma JJ; Freihorst J; von der Hardt H; Poets CF
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):725-31. PubMed ID: 11726398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant phosphatidylcholine metabolism and surfactant function in preterm, ventilated lambs.
    Jobe AH; Ikegami M; Seidner SR; Pettenazzo A; Ruffini L
    Am Rev Respir Dis; 1989 Feb; 139(2):352-9. PubMed ID: 2913884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure.
    Pison U; Obertacke U; Brand M; Seeger W; Joka T; Bruch J; Schmit-Neuerburg KP
    J Trauma; 1990 Jan; 30(1):19-26. PubMed ID: 2296063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma.
    Heeley EL; Hohlfeld JM; Krug N; Postle AD
    Am J Physiol Lung Cell Mol Physiol; 2000 Feb; 278(2):L305-11. PubMed ID: 10666114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compositional and functional changes of pulmonary surfactant in a guinea-pig model of chronic asthma.
    Cheng G; Ueda T; Sugiyama K; Toda M; Fukuda T
    Respir Med; 2001 Mar; 95(3):180-6. PubMed ID: 11266234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of lung contusion on surfactant composition in multiple-trauma patients.
    Aufinkolk M; Fischer R; Kleinschmidt C; Obertacke U; Schmit-Neuerburg KP
    J Trauma; 1996 Dec; 41(6):1023-9. PubMed ID: 8970557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.
    Hallman M; Spragg R; Harrell JH; Moser KM; Gluck L
    J Clin Invest; 1982 Sep; 70(3):673-83. PubMed ID: 6896715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise-induced alterations in phospholipid hydrolysis, airway surfactant, and eicosanoids and their role in airway hyperresponsiveness in asthma.
    Murphy RC; Lai Y; Nolin JD; Aguillon Prada RA; Chakrabarti A; Novotny MV; Seeds MC; Altemeier WA; Gelb MH; Hite RD; Hallstrand TS
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L705-L714. PubMed ID: 33533300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of surfactant lipids between pleural and pulmonary lining fluids.
    Mills PC; Chen Y; Hills YC; Hills BA
    Pulm Pharmacol Ther; 2006; 19(4):292-6. PubMed ID: 16168690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemic and endotoxin pre-conditioning reduce lung reperfusion injury-induced surfactant alterations.
    Markart P; Schmidt R; Ruppert C; Höres C; Silber RE; Börgermann J; Günther A; Friedrich I
    J Heart Lung Transplant; 2005 Oct; 24(10):1680-9. PubMed ID: 16210147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.